Logo
x

Search

Subscribe Now

Roche

Roche Reports the P-IIb (PADOVA) Trial Data of Prasinezumab for Early-Stage Parkinson’s Disease

Roche Reports the P-IIb (PADOVA) Trial Data of Prasinezumab for Early-Stage Parkinson’s Disease

  • December 20, 2024
Roche Reports the EMA’s Approval of Vabysmo Prefilled Syringe (PFS) for three Retinal Conditions Causing Blindness

Roche Reports the EMA’s Approval of Vabysmo Prefilled Syringe (PFS) for three Retinal Conditions Causing Blindness

  • December 13, 2024
Roche Highlights 5-year Analysis from P-III (POLARIX) Study of Polivy (Polatuzumab Vedotin) for Diffuse Large B-Cell Lymphoma (DLBCL) at ASH 2024

Roche Highlights 5-year Analysis from P-III (POLARIX) Study of Polivy (Polatuzumab Vedotin) for Diffuse Large B-Cell Lymphoma (DLB...

  • December 9, 2024
US FDA’s Accepts sBLA of Roche's Columvi (Glofitamab) Combination to Treat R/R Diffuse Large B-Cell Lymphoma (DLBCL)

US FDA’s Accepts sBLA of Roche's Columvi (Glofitamab) Combination to Treat R/R Diffuse Large B-Cell Lymphoma (DLBCL)

  • December 5, 2024
Roche to Acquire Poseida Therapeutics for ~$1.5B

Roche to Acquire Poseida Therapeutics for ~$1.5B

  • November 26, 2024
Roche Reports 1-Year Data from P-IV (ELEVATUM) Study of Vabysmo (Faricimab) in Patients with Diabetic Macular Edema (DME)

Roche Reports 1-Year Data from P-IV (ELEVATUM) Study of Vabysmo (Faricimab) in Patients with Diabetic Macular Edema (DME)

  • October 21, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.